Naltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4

The purpose of this study is to evaluate naltrexone as an adjunct in alcoholic cocaine dependent patients; concurrent relapse prevention theory.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Alcohol-Related Disorders Alcoholism Chemically-Induced Disorders Cocaine-Related Disorders Mental Disorders Substance-Related Disorders

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

University of Texas Health Science Center

Houston, Texas, 77225, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Please contact site for information.

Treatment and study plan

Naltrexone

Drug

Primary outcomes

Verified abstinence from cocaine

Time frame: over the 12 weeks of study

Sponsors and collaborators

Lead sponsor

National Institute on Drug Abuse (NIDA)

Nih

Collaborators

University of Texas

Registry information

Official study title

Naltrexone as an Adjunct in Alcoholic Cocaine Dependent Patients

Important dates

Study start: 2003
Primary completion: 2007
Study completion: 2007
First posted: Sep 21, 1999
Registry last updated: Jan 12, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed